ARUP's Laboratory Test Directory
| 0096666: Paroxysmal Nocturnal Hemoglobinuria Profile, High Resolution - WBC |
| Test Mnemonic: PNH-WBC | |
|
Methodology: Flow Cytometry
Performed: Sun-Sat Reported: 2-4 days |
| Specimen Required: | |
|
Collect: One 5 mL green (sodium or lithium heparin), lavender (EDTA), or pink (K2EDTA).
Transport: 5 mL whole blood at 2-8°C. Pediatric Collection/Transport: 2 mL whole blood at 2-8°C. Stability: Ambient: 24 hours; Refrigerated: 2 days; Frozen: Unacceptable |
|
| Reference Interval: | |||||||||
|
| Interpretive Data: | |
|
The High Resolution PNH-WBC panel detects the absence of phosphatidylinositol-linked membrane proteins CD55 (DAF-decay accelerating factor) and CD59 (MIRL-membrane inhibitor of reactive lysis) on neutrophils (PMNs). The PMNs are identified with CD11b staining. All normal PMNs (99.997-100.000%) express CD55 and CD59 and are reported as % Normal PMNs. The expression of CD55 and CD59 is decreased or absent in a subpopulation of PMNs in patients with paroxysmal nocturnal hemoglobinuria. The estimated percentage of PMNs with decreased expression is reported as % PNH cells. The detection of a very low percentile of PNH cells (0.004-1.000%) may be found in patients with aplastic anemia, myelodysplasia, refractory anemia, refractory anemia with excess blasts, and myelofibrosis. The presence of PNH cells in these patients may correlate with a better prognosis. Blood 102:1211-1218 (2003) Please refer to Statement A in the Compliance Statements section in the front of the Laboratory Test Directory. |
| CPT Code(s): | |
| 88184 First marker; 88185 x2 Each additional marker |